CCT2 and cancer: Using two cancer cell lines [triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)] that highly expressed CCT2, depletion of this subunit decreased anti-apoptotic proteins like XIAP and inhibited phosphorylation of AKT and GSK3.